acute myocardial infarction - myocardial Revascularization - Elderly patients clinical trials results meta-analysis

<h1> <a href="TM1-1-myocardial Revascularization-acute myocardial infarction" > <strong>acute myocardial infarction</strong> - myocardial Revascularization </a> - Elderly patients trial results systematic overview and meta-analysis </h1> <h2>Main characteristics of the included studies</h2> <table> <tr> <th>Trial</th> <th>Treatments</th> <th>Patients</th> <th>Methods</th> </tr> <tr> <td> <a href="../TRC_t9541.htm"> senior PAMI, 2005 </a> <br> NCT00136929 </td> <td> primary percutaneous coronary intervention<br>  <i>versus</i> <br> intravenous thrombolytic therapy </td> <td> elderly (age >= 70 years) patients with acute myocardial infarction </td> <td> follow-up 30 days<br> n=252/229<br> Parallel groups<br> Open <br> </td> </tr> <tr> <td> <a href="../TRC_t9691.htm"> TRIANA, 2009 </a> <br> NCT00257309 </td> <td> Tenecteplase + UFH (+/- clopidogrel)<br>  <i>versus</i> <br> Primary angioplasty </td> <td> >=75 years old with ST-segment elevation or LBBB AMI <6 hours of evolution without contraindications for thrombolytic therapy </td> <td> follow-up 30 days (12 months)<br> n=132/134<br> Parallel groups<br> open <br> </td> </tr> </table> <h2>References</h2> <p> <b>TRIANA, 2009 : </b> Clauw et alThe efficacy and safety of milnacpran in the treatment of fibromyalgia <i>2007, poster 716</i> [PMID ] </p>